28. Grandone E., De Stefano V., Rossiet E. et al. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants // Blood Coagul. Fibrinolysis. 2008. Vol. 19, № 3. P. 226–230.
29. Rey E., Kahn S.R., David M. et al. Thrombophilic disorders and fetal loss: a meta-analysis // Lancet. 2003. Vol. 15, № 361. P. 901–908.
30. Kovalevsky G., Gracia C.R., Berlin J.A. et al. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis // Arch. Intern. Med. 2004. Vol. 164, № 5. P. 558–563.
31. Meinardi J.R. Middeldorp S., de Kam P.J. et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation // Ann. Intern. Med. 1999. Vol. 130, № 9. P. 736–739.
32. Tormene D., Simioni P., Prandoni P. et al. The risk of fetal loss in family members of probands with factor V Leiden mutation // Thromb. Haemost. 1999. Vol. 82, № 4. P. 1237–1239.
33. Robertson L., Wu O., Langhorne P. et al. Thrombophilia in pregnancy: a systematic review // Br. J. Haematol. 2006. Vol. 132, № 2. P. 171–196.
34. Kujovich J.H. Thrombophilia and pregnancy complications // Am. J. Obstet. Gynecol. 2004. Vol. 191, № 2. С. 412–424.
35. Kutteh W.H., Triplett D. A Thrombophilias and recurrent pregnancy loss // Semin. Reprod. Med. 2006. Vol. 24, № 1. C. 54–66.
36. Pabinger I., Vormittag R. Thrombophilia and pregnancy outcomes // Thromb. Haemost. 2005. Vol. 3, № 8. P. 1603–1610.
37. Brenner B., Grabowski E., Hellgren M., Kenet G. Thrombophilia and pregnancy complications // Thromb. Haemost. 2004. Vol. 92, № 4. P. 678–681.
38. Савельева Г.М., Федорова М.В., Клименко П.А. и др. Плацентарная недостаточность. М.: Медицина, 1991. 276 с.
39. Vora S., Shetty S., Salvi V., Satoskar P. Thrombophilia and unexplained pregnancy loss in Indian patients // Natl. Med. J. India. 2008. Vol. 21, № 3. P. 116–119.
40. Coulam C.B., Jeyendran R.S., Fishel L.A., Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage // Am. J. Reprod. Immunol. 2006. Vol. 55, № 5. P. 360–368.
41. Rai R., Shlebak A., Cohen H. et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage // Hum. Reprod. 2001. Vol. 16, № 5. P. 961–965.
42. Carp H., Salomon O., Seidman D. et al. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss // Hum. Reprod. 2002. Vol. 17, № 6. P. 1633–1637.
43. Romerio S.C., Linder L., Nyfeler J. et al. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults // Atherosclerosis. 2004. Vol. 176. P. 337–344.
44. Murphy R.P., Donoghue C., Nallen R.J. et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy // Arterioscler. Thromb. Vase. Biol. 2000. Vol. 20, № 1. P. 266–270.
45. Clark P., Walker I.D., Govan L. et al. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes // Br. J. Haematol. 2008. Vol. 140, № 2. P. 236–240.
46. Демидова Е.М. и др. Роль эндометрия в генезе невынашивания беременности // Акушерство и гинекология. 2000. № 6. С. 11–13.
47. Репина М.А., Сумская Г.Ф., Лапина Е.Н. Наследственные нарушения системы гемостаза и беременность: методические рекомендации / ред. Айламазян Э.К. СПб.: Изд-во Н-Л, 2008. 40 с.
48. Lessey B.A. The role of the endometrium during embrio implantation // Hum. Reprod. 2000. Vol. 15, № 6. C. 39–50.
49. Verspyck E., Le Сam-Duchez V., Gravier A. et al. Small for gestational age infant in association with maternal prothrombin gene variant (nt 2021 OA) // Eur. J. Obstet. Gynecol. Reprod. Biol. 1999. Vol. 83, № 2. P. 143–144.
50. Dolitzky M., Inbal A., Segal Y. et al. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages // Fertil. Steril. 2006. Vol. 86, № 2. P. 362–366.
51. Weiler-Guettler H., Aird W.C., Rayburn H. et al. Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos // Development. 1996. Vol. 122, № 7. C. 2271–2281.
52. Crawley J.T., Gu J.M., Ferrell G., Esmon C.T. Distribution of endothelial cell protein C/activated protein C receptor (EPCR) during mouse embryo development // Thromb. Haemost. 2002. Vol. 88, № 2. C. 259–266.
53. Edstrom C.S., Calhoun D.A., Christensen R.D. Expression of the proliferation markers Ki67 and transferring receptor by human trophoblast populations / Expression of tissue factor pathway inhibitor in human fetal and placental tissues // Early Hum. Dev. 2000. Vol. 59, № 2. C. 77–84.
54. Sood R., Kalloway S., Mast A.E. et al. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells // Blood. 2006. Vol. 107, № 8. P. 3173–3180.